Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Pek Yeng Chong
Introduction
Pek Yeng Chong is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target CCR5-related diseases.
Latest Patents
One of her key patents is titled "Heterocyclic compounds as CCR5 antagonists." This invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, which are useful in the treatment of CCR5-related diseases and disorders. Specifically, these compounds are effective in inhibiting HIV replication, preventing or treating HIV infections, and addressing the resulting acquired immune deficiency syndrome (AIDS). Pek Yeng Chong holds 1 patent in this area.
Career Highlights
Pek Yeng Chong is associated with SmithKline Beecham Corporation, where she has been instrumental in advancing research and development in her field. Her work has contributed to the understanding and treatment of critical health issues.
Collaborations
Throughout her career, Pek Yeng Chong has collaborated with esteemed colleagues, including Christopher Joseph Aquino and Maosheng Duan. These partnerships have fostered innovation and enhanced the impact of her research.
Conclusion
Pek Yeng Chong's contributions to the field of pharmaceuticals, particularly through her patent on CCR5 antagonists, highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of HIV and related diseases.